CleanSpace Holdings Past Earnings Performance
Past criteria checks 0/6
CleanSpace Holdings's earnings have been declining at an average annual rate of -58.5%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 64.5% per year.
Key information
-58.5%
Earnings growth rate
-58.0%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | -64.5% |
| Return on equity | -27.2% |
| Net Margin | -39.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Does CleanSpace Holdings (ASX:CSX) Have A Healthy Balance Sheet?
Apr 18
CleanSpace Holdings (ASX:CSX) Is Achieving High Returns On Its Capital
Nov 29CleanSpace Holdings Limited's (ASX:CSX) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 21Some CleanSpace Holdings Limited (ASX:CSX) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 31Should You Be Impressed By CleanSpace Holdings Limited's (ASX:CSX) ROE?
Feb 18
Here's Why We Don't Think CleanSpace Holdings's (ASX:CSX) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 23Revenue & Expenses BreakdownBeta
How CleanSpace Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 14 | -5 | 16 | 1 |
| 30 Sep 23 | 13 | -7 | 17 | 1 |
| 30 Jun 23 | 12 | -8 | 18 | 1 |
| 31 Mar 23 | 12 | -9 | 20 | 1 |
| 31 Dec 22 | 12 | -11 | 21 | 1 |
| 30 Sep 22 | 13 | -11 | 22 | 1 |
| 30 Jun 22 | 13 | -11 | 22 | 2 |
| 31 Mar 22 | 15 | -9 | 21 | 2 |
| 31 Dec 21 | 17 | -7 | 20 | 1 |
| 30 Sep 21 | 34 | 2 | 20 | 1 |
| 30 Jun 21 | 50 | 11 | 20 | 1 |
| 31 Mar 21 | 55 | 16 | 19 | 1 |
| 31 Dec 20 | 61 | 20 | 19 | 2 |
| 30 Sep 20 | 45 | 13 | 16 | 1 |
| 30 Jun 20 | 28 | 6 | 13 | 1 |
| 30 Jun 19 | 11 | -1 | 8 | 1 |
| 30 Jun 18 | 8 | -1 | 6 | 1 |
| 30 Jun 17 | 5 | -2 | 4 | 1 |
Quality Earnings: CSX is currently unprofitable.
Growing Profit Margin: CSX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CSX is unprofitable, and losses have increased over the past 5 years at a rate of 58.5% per year.
Accelerating Growth: Unable to compare CSX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CSX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: CSX has a negative Return on Equity (-27.24%), as it is currently unprofitable.